weight loss medicine semaglutide Novo Nordisk's weight-loss pill wins FDA approval Trending weight loss drug hits
Description
Abbreviations: 5 AMP, 5 adenosine monophosphate
GLP1a have been shown to promote further weight loss in patients following MBS
Extracted data included: population characteristics, intervention type/dose, phenotype stratification, weight loss magnitude, and complication-specific outcomes
Diabetes Care 2023;46(5): e121e122
SEM 1 mg: 3.56 kg, 95% CI 4.74 to 2.38) (Table 30)
